LENZ THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.35 USD | -1.09% |
|
+3.94% | 0.00% |
| 04-15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
| 04-15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- LENZ Stock
- Revisions LENZ Therapeutics, Inc.
